Therapeutic intervention in glomerulonephritis by oligonucleotides

Experimental Nephrology

Volumn 5, Issue 2, 1997, Pages 126-131

  Kashihara, Naoki ^a   Maeshima, Yohei ^a   Makino, Hirofumi ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

antisense; decoy; oligonucleotide; ribozyme

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; OLIGONUCLEOTIDE;

GENE TRANSFER; GLOMERULONEPHRITIS; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; CELL CYCLE; GENE THERAPY; GLOMERULAR MESANGIUM; GLOMERULONEPHRITIS; HUMANS; NUCLEAR PROTEINS; OLIGONUCLEOTIDES, ANTISENSE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MYB; PROTO-ONCOGENE PROTEINS C-MYC; PROTO-ONCOGENES; RNA, CATALYTIC; TRANS-ACTIVATORS;

EID: 0030936996     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Wagner RW: Gene inhibition using antisense oligodeoxynucleotides. Nature 1994;372:333-335.
2. Simons M, Edelman ER, Dekeyser J-L, Langer R, Rosenberg RD: Antisense c-myb oligonucleotides inhibit intimai arterial smooth muscle cell accumulation in vivo. Nature 1992;359: 67-70.
3. Bennet MR, Anglin S, McEwan JR, Jagoe R, Newby AC, Evan GI: Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides. J Clin Invest 1994;93:820-828.
4. Lisziewicz J, Sun D, Wichold F, Thierry A, Lusso P, Tang J, Gallo R, Agrawal S: Antisense oligonucleotide phosphorothioate complementary to Gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cells. Proc Natl Acad Sci USA 1995;91:7942-7946.
5. Bayever E, Iversen P, Smith L, Spinolo J, Zon G: Systemic antisense therapy begins. Antisense Res 1992;2:109-110.
6. Morishita R, Gibbons G, Horiuchi M, Ellison K, Nakajima M, Zhang L, Kaneda Y, Ogihara T, Dzau V: A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo. Proc Natl Acad Sci USA 1995;92:5855-5859.
7. Cech T, Bass B: Biological catalysis by RNA. Annu Rev Biochem 1986;55:599-629.
8. Dean M, McKay R, Codon T, Bennet C: Inhibition of protein kinase-α expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters. J Biol Chem 1994;269:16416-16424.
9. Lasic D, Papahadjopoulos D: Liposomes revisited. Science 1995;267:1275-1276.
10. Burgess TL, Fisher EF, Ross SL, Bready JV, Qian Y, Bayewitch LA, Cohen AM, Herrera CJ, Hu SSF, Kramer TB, Lott FD, Martin FH, Pierce GF, Simonet L, Farrell CL: The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism. Proc Natl Acad Sci USA 1995;92:4051-4055.
11. Perez JR, Li Y, Stein CA, Majumder S, Oorschot AV, Narayanan R: Sequence-independent induction of Sp1 transcription factor activity by phosphorothioate oligodeoxynucleotides. Proc Natl Acad Sci USA 1994;91:5957-5961.
12. Woolf T, Melton D, Jennings C: Specificity of antisense oligonucleotides in vivo. Proc Natl Acad Sci USA 1992;89:7305-7309.
13. Rappaport J, Hanss B, Kopp JB, Copeland TD, Bruggeman LA, Coffman TM, Klotman PE: Transport of phosphorothioate oligonucleotides in kidney: Implications for molecular therapy. Kidney Int 1995;47:1462-1469.
14. Kashihara N, Maeshima Y, Sugiyama H, Sekikawa T, Okamoto K, Morita, Y, Kanao K, Yamasaki Y, H. M, Ota Z: Inhibitory effects of antisense oligonucleotides targeting proto-oncogene mRNA on mesangial cell proliferation (abstract). J Am Soc Nephrol 1994;5:754.
15. Maeshima Y, Kashihara N, Sugiyama H, Makino H, Ota Z: Inhibition of human mesangial cell proliferation by antisense proliferating cell nuclear antigen and Ki-67. J Am Soc Nephrol, in press.
16. Travali S, Ku D-H, Rizzo MG, Ottavio L, Baserga R, Calabretta B: Structure of the human gene for the proliferating cell nuclear antigen. J Biol Chem 1989;264:7466-7472.
17. Schluter C, Duchrow M, Wohlenberg C, Becker MHG, Key G, Had H-D, Gerdes J: The cell proliferation-associated antigen of antibody Ki-67: A very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J Cell Biol 1993;123:513-522.
18. Hofer G, Grimmer C, Sukhatme V, Sterzel R, Rupprecht H: The transcription factor Egr-1 regulates mesangial cell proliferation (abstract). J Am Soc Nephrol 1995;6:768.
19. Albrightson C, Nambi P, Ganz M: Effect of protein kinase CbII (PKC) antisense oligonucleotides on proliferation of rat glomerular mesangial cells (abstract). J Am Soc Nephrol 1995; 6:782.
20. Johnson RJ, Raines EW, Floege J, Yoshimura A, Pritzl P, Alpers C, Ross R: Inhibition of mesangial cell proliferation and matrix expression in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med 1992;175:1413-1416.
21. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbancher MD, Ruoslahti E: Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 1992;360: 361-364.
22. Maeshima Y, Kashihara N, Sugiyama H, Sekikawa T, Okamoto K, Morita Y, Kanao K, Yamasaki Y, H. M, Ota Z: Inhibition of mesangial cell proliferation and matrix expansion by antisense oligonucleotides targeting platelet derived growth factor and transforming growth factor-β mRNA in vivo (abstract). J Am Soc Nephrol 1994;5:835.
23. Akagi Y, Isaka Y, Arai M, Kaneko T, Takenaka M, Moriyama T, Kaneda Y, Ando A, Ueda N, Imai E: Antisense oligonucleotides for TGF-β1 suppressed glomerulosclerosis through the suppression of phenotypic change of mesangial cells (abstract). J Am Soc Nephrol 1995;6:860.
24. Nevins J: E2F: A link between the Rb tumor suppressor protein and viral oncoproteins. Science 1992;258:424-429.
25. Tomita N, Kim J, Gibbons G, Batran D, Ogborn M, Stahl R, Tomita S, Zhang L, Kaneda Y, Dzau V: In vivo gene therapy of anti-Thy1 nephritis using E2F decoy oligonucleotide (abstract). J Am Soc Nephrol 1995;6:887.
26. Khachigian L, Collins T, Fries W: Nuclear factor-kB mediates induction of vascular cell adhesion molecule-1 in glomerular mesangial cells. Biochem Biophys Res Commun 1995; 206:462-467.
27. Kashihara N, Maeshima Y, Sekikawa T, Okamoto K, Kanao K, Sugiyama H, Makino H, Ota Z, Yasuda T: Inhibition of human mesangial proliferation by decoy oligonucleotide targeting the transcription factor, NF-kappa B (abstract). J Am Soc Nephrol 1995;6:834.
28. Hendry P, McCall MJ: A comparison of the in vitro activity of DNA-armed and all-RNA hammerhead ribozymes. Nucleic Acids Res 1995;23:3928-3936.
29. Heidenreich O, Eckstein F: Hammerhead ribozyme-mediated cleavage of the long terminal repeat RNA of human immunodeficiency virus type 1. J Biol Chem 1992;267:1904-1909.